Direxion Daily S&P Biotech Bull 3x Shares Rating → Elon Musk Secret Crypto Plot Exposed (From Crypto 101 Media) (Ad) Free LABU Stock Alerts $101.63 -3.20 (-3.05%) (As of 05/10/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy2.70Holdings in LABU have an aggregate rating of Moderate Buy based on 505 analyst ratings issued in the past year covering 39 companies (29.1% of the portfolio).LABU Aggregate Price Target$128.4926.43% UpsideHigh Prediction$173.08Average Prediction$128.49Low Prediction$89.28Holdings in LABU have an aggregate price target of $128.49 and a range of $89.28 to $173.08 covering 39 companies (29.1% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 39 LABU Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.25%ALPNAlpine Immune Sciences$64.94+0.2%2 of 5 stars2.27$50.33 -22.5%11Short Interest ↓Positive News0.87%RVMDRevolution Medicines$37.25-0.5%4 of 5 stars3.10$41.60 11.7%10Earnings ReportAnalyst ForecastNews Coverage0.86%IBRXImmunityBio$8.12+0.7%0 of 5 stars2.00$6.00 -26.1%1Gap Down0.84%VKTXViking Therapeutics$73.64-8.2%5 of 5 stars3.00$112.25 52.4%100.81%MRNAModerna$117.31-4.4%3 of 5 stars2.25$126.89 8.2%16Analyst ForecastInsider Selling0.80%EXELExelixis$21.37-1.8%5 of 5 stars2.63$26.33 23.2%16Short Interest ↑0.79%NTRANatera$105.29+10.2%1 of 5 stars3.00$87.86 -16.6%15Earnings ReportAnalyst DowngradeInsider SellingNews CoverageGap UpHigh Trading Volume0.78%PTCTPTC Therapeutics$32.25+3.9%2 of 5 stars1.92$33.67 4.4%13Positive News0.78%CRNXCrinetics Pharmaceuticals$48.00-2.9%4 of 5 stars2.92$57.58 20.0%12Earnings ReportAnalyst ForecastInsider SellingShort Interest ↓News Coverage0.78%CERECerevel Therapeutics$42.19-0.3%0 of 5 stars2.11$42.67 1.1%9Short Interest ↓0.78%GERNGeron$3.80-2.1%4 of 5 stars2.80$6.10 60.5%5Gap Down0.77%SRPTSarepta Therapeutics$131.82-0.4%4 of 5 stars2.79$160.60 21.8%140.77%ROIVRoivant Sciences$11.13-1.1%3 of 5 stars2.90$16.90 51.8%10Positive News0.76%AMGNAmgen$310.15-0.9%5 of 5 stars2.52$305.65 -1.5%21Analyst Forecast0.75%EXASExact Sciences$53.51-1.2%5 of 5 stars2.92$95.40 78.3%13Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageHigh Trading Volume0.75%BPMCBlueprint Medicines$106.70-1.5%1 of 5 stars2.50$100.31 -6.0%16Short Interest ↑Analyst Revision0.75%NBIXNeurocrine Biosciences$136.70-2.1%5 of 5 stars2.74$147.88 8.2%230.73%UTHRUnited Therapeutics$264.27-0.7%5 of 5 stars2.90$308.78 16.8%10Insider Selling0.73%ALNYAlnylam Pharmaceuticals$150.47-0.6%4 of 5 stars2.59$216.19 43.7%17Analyst ForecastShort Interest ↑Analyst Revision0.73%BIIBBiogen$221.50-0.6%5 of 5 stars2.65$288.46 30.2%26Positive News0.72%VRTXVertex Pharmaceuticals$422.78+0.9%4 of 5 stars2.48$432.18 2.2%25Earnings ReportAnalyst Forecast0.72%DYNDyne Therapeutics$26.00+0.2%3 of 5 stars3.13$37.75 45.2%8Short Interest ↑Analyst Revision0.72%RYTMRhythm Pharmaceuticals$39.14+1.7%3 of 5 stars2.83$54.33 38.8%6Earnings ReportAnalyst Forecast0.71%IONSIonis Pharmaceuticals$39.08-1.0%4 of 5 stars2.71$59.54 52.4%14Earnings ReportAnalyst ForecastInsider SellingShort Interest ↓0.71%BMRNBioMarin Pharmaceutical$81.03-0.8%5 of 5 stars2.63$107.50 32.7%19Short Interest ↑0.70%CYTKCytokinetics$62.10-3.0%4 of 5 stars2.87$81.60 31.4%15Earnings ReportAnalyst ForecastInsider SellingNews Coverage0.69%ABBVAbbVie$160.75+0.2%4 of 5 stars2.77$174.31 8.4%13Earnings ReportShort Interest ↑0.69%HALOHalozyme Therapeutics$43.15-1.6%5 of 5 stars2.83$53.14 23.2%6Analyst Forecast0.69%SWTXSpringWorks Therapeutics$40.89-4.8%2 of 5 stars3.00$68.83 68.3%6Analyst Revision0.69%REGNRegeneron Pharmaceuticals$973.80+0.6%4 of 5 stars2.70$981.71 0.8%200.67%KRYSKrystal Biotech$154.76-2.5%5 of 5 stars3.00$171.00 10.5%9Earnings ReportShort Interest ↑Analyst RevisionNews Coverage0.67%IDYAIDEAYA Biosciences$41.17+1.3%3 of 5 stars3.00$47.50 15.4%12Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage0.67%INSMInsmed$25.97-1.6%4 of 5 stars3.00$45.08 73.6%12Earnings ReportAnalyst ForecastOptions VolumeNews Coverage0.67%BBIOBridgeBio Pharma$29.10+1.3%4 of 5 stars2.80$47.82 64.3%10Short Interest ↑0.66%GILDGilead Sciences$65.96+2.1%5 of 5 stars2.39$83.69 26.9%180.65%VCELVericel$48.10-1.1%1 of 5 stars3.00$46.80 -2.7%6Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.65%INCYIncyte$53.06-0.8%5 of 5 stars2.47$74.93 41.2%17Short Interest ↑0.65%IMVTImmunovant$29.39-1.0%3 of 5 stars3.00$48.00 63.3%17Short Interest ↑0.65%DVAXDynavax Technologies$10.73-2.5%4 of 5 stars2.75$25.33 136.1%4Analyst ForecastShort Interest ↑News Coverage This page (NYSEARCA:LABU) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & CompanyRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.